Advertisement
American Journal of Preventive Medicine
ACPM
APTR
Advanced searchSave search
Research Brief| Volume 56, ISSUE 3, P452-457, March 2019

Prevalence and Correlates of Diabetes Prevention Program Referral and Participation

  • Maya Venkataramani
    Correspondence
    Address correspondence to: Maya Venkataramani, MD, MPH, Division of General Internal Medicine, Johns Hopkins University School of Medicine, Suite 2-502, 2024 E Monument Street, Baltimore, MD 21287.
    Affiliations
    Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

    Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, Maryland
    Search for articles by this author
  • Craig Evan Pollack
    Affiliations
    Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

    Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, Maryland

    Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
    Search for articles by this author
  • Hsin-Chieh Yeh
    Affiliations
    Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

    Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, Maryland

    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
    Search for articles by this author
  • Nisa M. Maruthur
    Affiliations
    Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

    Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, Maryland

    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
    Search for articles by this author
Published:January 17, 2019DOI:https://doi.org/10.1016/j.amepre.2018.10.005
Prevalence and Correlates of Diabetes Prevention Program Referral and Participation
Previous ArticleA National Comparison of Suicide Among Medicaid and Non-Medicaid Youth
Next ArticleTemporal Patterns in Chlamydia Repeat Testing in Massachusetts

      Introduction

      As the burden of type 2 diabetes rises, there is increasing focus on improving the reach of evidence-based lifestyle interventions. Using nationally representative data, this study identifies how frequently at-risk adults are being referred to and participating in diabetes prevention programming, and explores correlates of referral, participation, and interest.

      Methods

      Data from the 2016 National Health Interview Survey, a cross-sectional survey of U.S. households, were analyzed in 2017. The study population consisted of adults (aged ≥18 years) without a self-reported diabetes diagnosis, who were likely eligible for diabetes prevention programming based on (1) self-reported diagnosis of prediabetes or gestational diabetes, and (2) meeting BMI criteria. Prevalence of self-reported referral and participation was determined, and sociodemographic correlates of referral, participation, and interest were characterized through multivariable logistic regression analyses.

      Results

      The study population consisted of 2,341 adults. The majority were female (63%), white (74.6%), non-Hispanic (83.4%), and aged ≥45 years (68.2%). A total of 4.2% reported ever being referred to a 12-month prevention program and only 2.4% reported ever participating. In multivariable logistic regression, race was correlated with referral (black and Asian adults more likely to report referral) and age was positively correlated with participation. More than 25% of adults who were never referred or participated reported an interest in engaging in programming.

      Conclusions

      Although more than one quarter of adults likely eligible for diabetes prevention programming express interest in participating, few are being referred and fewer still have participated. This underscores the need for efforts to enhance program referral and access.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

      1. CDC. National Diabetes Statistics Report. Estimates of diabetes and its burden in the United States, 2017. Atlanta, GA: DHHS.www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf.Published 2017. Accessed March 24, 2018.

        View in Article
        • Diabetes Prevention Program Research Group
        Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
        N Engl J Med. 2002; 346: 393-403
        https://doi.org/10.1056/NEJMoa012512
        View in Article
        • Schellenberg ES
        • Dryden DM
        • Vandermeer B
        • Ha C
        • Korownyk C
        Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis.
        Ann Intern Med. 2013; 159: 543-551
        https://doi.org/10.7326/0003-4819-159-8-201310150-00007
        View in Article
        • Albright AL
        • Gregg EW
        Preventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program.
        Am J Prev Med. 2013; 44: S346-S351
        https://doi.org/10.1016/j.amepre.2012.12.009
        View in Article
        • Ely EK
        • Gruss SM
        • Luman ET
        • et al.
        A national effort to prevent type 2 diabetes: participant-level evaluation of CDC's National Diabetes Prevention Program.
        Diabetes Care. 2017; 40: 1331-1341
        https://doi.org/10.2337/dc16-2099
        View in Article
        • CDC
        Centers for Disease Control and Prevention Diabetes Prevention Recognition Program. Standards and Operating Procedures.
        www.cdc.gov/diabetes/prevention/pdf/dprp-standards.pdf
        Date: 2015
        Date accessed: January 28, 2018
        (Published January 1,)
        View in Article

      7. National Commission on Prevention Priorities. Preventive care: a national profile on use, disparities, and health benefits. Washington, DC: Partnership for Prevention. www.prevent.org/data/files/initiatives/ncpppreventivecarereport.pdf.Published 2007. Accessed June 3, 2018.

        View in Article

      8. American Association of Retired Persons Public Policy Institute. Use of clinical preventive services and prevalence of health risk factors among adults aged 50–64: national and state-level racial/ethnic, socioeconomic, and health insurance coverage status disparities. Washington, DC: AARP Public Policy Institute.www.aarp.org/content/dam/aarp/research/public_policy_institute/health/2013/clinical-preventive-services-and-prevalence-of-health-risks-AARP-ppi-health.pdf.Published 2013. Accessed June 6, 2018.

        View in Article
        • Ahern AL
        • Aveyard P
        • Boyland EJ
        • et al.
        Inequalities in the uptake of weight management interventions in a pragmatic trial: an observational study in primary care.
        Br J Gen Pract. 2016; 66: e258-e263
        https://doi.org/10.3399/bjgp16X684337
        View in Article
        • Mehta S
        • Mocarski M
        • Wisnieski T
        • Gillespie K
        • Narayan KM
        • Lang K
        Primary care physicians’ utilization of type 2 diabetes screening guidelines and referrals to behavioral interventions: a survey-linked retrospective study.
        BMJ Open Diabetes Res Care. 2017; 5e000406.
        https://doi.org/10.1136/bmjdrc-2017-000406
        View in Article
        • Center for Medicare and Medicaid Services
        Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2018; Medicare Shared Savings Program Requirements; and Medicare Diabetes Prevention Program. Final rule.
        Fed Regist. 2017; 82: 52976-53371
        www.gpo.gov/fdsys/pkg/FR-2017-11-15/pdf/2017-23953.pdf
        Date accessed: March 24, 2018
        View in Article

      12. CDC. New AMA, CDC Initiative Aims to “Prevent Diabetes STAT.” Atlanta, GA: CDC. www.cdc.gov/media/releases/2015/p0311-diabetes-stat.html.Published March 2015. Accessed June 5, 2018.

        View in Article
        • Ritchie ND
        • Sauder KA
        • Fabbri S
        Reach and effectiveness of the National Diabetes Prevention Program for young women.
        Am J Prev Med. 2017; 53: 714-718
        https://doi.org/10.1016/j.amepre.2017.06.013
        View in Article

      Article info

      Publication history

      Published online: January 17, 2019

      Identification

      DOI: https://doi.org/10.1016/j.amepre.2018.10.005

      Copyright

      © 2018 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX